About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Aurobindo Pharma Gets Tentative FDA Approval for Famciclovir

by Kathy Jones on January 31, 2011 at 9:26 PM
Font : A-A+

 Aurobindo Pharma Gets Tentative FDA Approval for Famciclovir

The US Food and Drug Administration has given a tentative approval for Aurobindo Pharma to market the generic Famciclovir tablets which are used to treat herpes virus infections.

According to the statement by the company, the FDA has given its approval for the manufacture of the drug in three variants, 125 mg, 250 mg and 500 mg.

Advertisement

"The product has a market size of approximately $170 million for the twelve months ending September 30, 2010, according to the IMS", the company added.


Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 10 Foods for Decreasing DHT Production and Preventing Hair Fall
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Most Popular on Medindia

Sinopril (2mg) (Lacidipine) Nutam (400mg) (Piracetam) The Essence of Yoga Drug Interaction Checker Find a Doctor Diaphragmatic Hernia Color Blindness Calculator Drug Side Effects Calculator Pregnancy Confirmation Calculator Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT ONLINE WITH A DOCTOR

×

Aurobindo Pharma Gets Tentative FDA Approval for Famciclovir Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests